HPGC Renmintongtai Pharmaceutical Corp - Asset Resilience Ratio
HPGC Renmintongtai Pharmaceutical Corp (600829) has an Asset Resilience Ratio of 0.00% as of September 2010. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read HPGC Renmintongtai Pharmaceutical Corp balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1995–2009)
This chart shows how HPGC Renmintongtai Pharmaceutical Corp's Asset Resilience Ratio has changed over time. See net assets of HPGC Renmintongtai Pharmaceutical Corp for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down HPGC Renmintongtai Pharmaceutical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600829 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥8.20K | 0.0% |
| Total Liquid Assets | CN¥8.20K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: HPGC Renmintongtai Pharmaceutical Corp maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
HPGC Renmintongtai Pharmaceutical Corp Industry Peers by Asset Resilience Ratio
Compare HPGC Renmintongtai Pharmaceutical Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
Drug Manufacturers - Specialty & Generic | 0.44% |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE |
Drug Manufacturers - Specialty & Generic | 1.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
Drug Manufacturers - Specialty & Generic | 2.69% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 20.24% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
Annual Asset Resilience Ratio for HPGC Renmintongtai Pharmaceutical Corp (1995–2009)
The table below shows the annual Asset Resilience Ratio data for HPGC Renmintongtai Pharmaceutical Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2009-12-31 | 0.00% | CN¥65.16K ≈ $9.53K |
CN¥2.85 Billion ≈ $417.56 Million |
0.00pp |
| 2008-12-31 | 0.00% | CN¥87.24K ≈ $12.77K |
CN¥2.91 Billion ≈ $426.49 Million |
-0.22pp |
| 2007-12-31 | 0.22% | CN¥5.85 Million ≈ $856.25K |
CN¥2.68 Billion ≈ $392.22 Million |
+0.13pp |
| 2006-12-31 | 0.09% | CN¥2.00 Million ≈ $292.85K |
CN¥2.24 Billion ≈ $327.69 Million |
+0.08pp |
| 2003-12-31 | 0.00% | CN¥53.00K ≈ $7.76K |
CN¥1.08 Billion ≈ $157.58 Million |
+0.00pp |
| 2002-12-31 | 0.00% | CN¥1.00K ≈ $146.33 |
CN¥929.89 Million ≈ $136.07 Million |
-2.00pp |
| 2000-12-31 | 2.00% | CN¥20.00 Million ≈ $2.93 Million |
CN¥1.00 Billion ≈ $146.49 Million |
-1.67pp |
| 1999-12-31 | 3.66% | CN¥26.00 Million ≈ $3.80 Million |
CN¥709.69 Million ≈ $103.85 Million |
-0.05pp |
| 1998-12-31 | 3.72% | CN¥25.00 Million ≈ $3.66 Million |
CN¥672.44 Million ≈ $98.40 Million |
+0.69pp |
| 1997-12-31 | 3.03% | CN¥20.23 Million ≈ $2.96 Million |
CN¥667.48 Million ≈ $97.67 Million |
-0.17pp |
| 1996-12-31 | 3.20% | CN¥20.69 Million ≈ $3.03 Million |
CN¥646.29 Million ≈ $94.57 Million |
-0.98pp |
| 1995-12-31 | 4.18% | CN¥26.50 Million ≈ $3.88 Million |
CN¥634.21 Million ≈ $92.81 Million |
-- |
About HPGC Renmintongtai Pharmaceutical Corp
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosm… Read more